HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jen-Yu Hung Selected Research
Jen-Yu Hung Research Topics
Disease
44
Neoplasms (Cancer)
01/2024 - 01/2006
43
Lung Neoplasms (Lung Cancer)
03/2023 - 03/2002
28
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 11/2006
24
Adenocarcinoma of Lung
03/2024 - 11/2009
21
Neoplasm Metastasis (Metastasis)
03/2024 - 01/2006
7
Breast Neoplasms (Breast Cancer)
02/2016 - 08/2007
6
Carcinogenesis
12/2021 - 11/2006
5
Inflammation (Inflammations)
02/2018 - 08/2007
4
Disease Progression
11/2023 - 10/2006
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 11/2009
3
Asthma (Bronchial Asthma)
02/2018 - 04/2016
3
Bone Resorption
05/2015 - 06/2013
2
Adenocarcinoma
12/2022 - 10/2017
2
Drug-Related Side Effects and Adverse Reactions
05/2021 - 12/2017
2
Carcinoma (Carcinomatosis)
01/2016 - 02/2010
2
Lewis Lung Carcinoma
06/2013 - 03/2012
2
Melanoma (Melanoma, Malignant)
05/2007 - 01/2006
2
Pneumonia (Pneumonitis)
10/2006 - 04/2002
1
Hypertension (High Blood Pressure)
03/2024
1
Malignant Mesothelioma
12/2021
1
Colorectal Neoplasms (Colorectal Cancer)
12/2021
Drug/Important Bio-Agent (IBA)
20
ErbB Receptors (EGF Receptor)
IBA
03/2024 - 01/2010
16
Tyrosine Kinase Inhibitors
IBA
03/2024 - 01/2010
10
Proteins (Proteins, Gene)
FDA Link
09/2021 - 01/2006
8
Conditioned Culture Media
IBA
02/2016 - 08/2011
7
Platinum
IBA
11/2023 - 01/2016
6
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2024 - 08/2007
6
Galectin 1 (LGALS1)
IBA
11/2017 - 02/2011
6
Flavonoids
IBA
03/2016 - 06/2010
5
MicroRNAs (MicroRNA)
IBA
01/2023 - 06/2013
5
Gefitinib (Iressa)
FDA Link
01/2022 - 01/2010
5
Cytokines
IBA
02/2018 - 11/2008
5
Small Interfering RNA (siRNA)
IBA
09/2017 - 03/2012
4
Afatinib
IBA
03/2023 - 12/2017
4
Ligands
IBA
01/2023 - 02/2015
4
Chemokines
IBA
02/2018 - 04/2002
4
Antineoplastic Agents (Antineoplastics)
IBA
01/2013 - 06/2010
3
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2020
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 12/2020
3
leukotriene D4 receptor (cysteinyl leukotriene receptor)
IBA
12/2021 - 04/2016
3
Anaplastic Lymphoma Kinase
IBA
10/2021 - 04/2021
3
DNA (Deoxyribonucleic Acid)
IBA
02/2020 - 02/2011
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2018 - 08/2007
3
Interleukin-10 (Interleukin 10)
IBA
12/2016 - 02/2011
3
Glycosides
IBA
02/2016 - 09/2008
3
Parathyroid Hormone-Related Protein
IBA
05/2015 - 06/2013
3
Interleukin-8 (Interleukin 8)
IBA
12/2014 - 04/2010
2
Bevacizumab (Avastin)
FDA Link
03/2024 - 01/2023
2
Metalloproteases (Metalloproteinases)
IBA
05/2022 - 03/2012
2
Disintegrins
IBA
05/2022 - 03/2012
2
Pemetrexed (MTA)
FDA Link
12/2021 - 01/2016
2
alectinib
IBA
10/2021 - 04/2021
2
lorlatinib
IBA
10/2021 - 04/2021
2
Cell Adhesion Molecules
IBA
06/2021 - 05/2019
2
Coal (Coals)
IBA
01/2021 - 03/2015
2
Antibodies
IBA
01/2021 - 11/2013
2
Allergens
IBA
02/2018 - 05/2015
2
Enzymes
IBA
09/2017 - 03/2012
2
laricitrin
IBA
12/2016 - 03/2016
2
Benzo(a)pyrene
IBA
03/2016 - 05/2015
2
4-boronic acid benzophenone
IBA
02/2016 - 12/2015
2
Esters
IBA
02/2016 - 12/2014
2
didymin
IBA
02/2016 - 06/2010
2
phthalic acid (phthalate)
IBA
02/2016 - 12/2014
2
Integrins
IBA
10/2015 - 06/2013
2
Carrier Proteins (Binding Protein)
IBA
10/2015 - 06/2013
2
CC Chemokines
IBA
08/2015 - 02/2015
2
Macrophage Colony-Stimulating Factor
IBA
08/2015 - 02/2015
2
shogaol
IBA
02/2015 - 10/2009
2
Heparin-binding EGF-like Growth Factor (HB-EGF)
IBA
07/2014 - 03/2012
2
Serine (L-Serine)
FDA Link
01/2013 - 11/2008
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
02/2010 - 11/2009
1
Ramucirumab
IBA
03/2024
1
osimertinib
IBA
01/2024
1
AC133 Antigen
IBA
01/2024
1
Long Noncoding RNA
IBA
01/2024
1
amivantamab-vmjw
IBA
11/2023
1
Complement System Proteins (Complement)
IBA
01/2023
1
Lipids
IBA
01/2023
1
A-factor (Streptomyces)
IBA
12/2022
1
Eukaryotic Initiation Factor-4A (Eukaryotic Initiation Factor 4A)
IBA
06/2022
1
B7-H1 Antigen
IBA
05/2022
1
Thrombospondins
IBA
05/2022
1
atezolizumab
IBA
01/2022
1
cysteinyl-leukotriene
IBA
12/2021
1
Matrix Metalloproteinases (MMPs)
IBA
12/2021
1
Crizotinib
IBA
10/2021
1
Cell-Free Nucleic Acids
IBA
10/2021
1
ceritinib
IBA
10/2021
1
brigatinib
IBA
10/2021
1
Amine Oxidase (Copper-Containing)
IBA
09/2021
1
Messenger RNA (mRNA)
IBA
09/2021
1
Oxidoreductases (Dehydrogenase)
IBA
09/2021
1
Amines
IBA
09/2021
1
limbic system-associated membrane protein
IBA
06/2021
Therapy/Procedure
19
Therapeutics
03/2024 - 01/2006
16
Drug Therapy (Chemotherapy)
11/2023 - 03/2002
6
Immunotherapy
05/2022 - 05/2007
3
Salvage Therapy
12/2021 - 01/2016
3
Radiotherapy
01/2021 - 07/2019